Technological Advancements by Key Players in the Field of Transplant Diagnostics – Explore

Organ transplantation in one of the greatest innovations in the healthcare industry indeed. This technology has come a long way in the past couple of years.  With a lot of advancements and modern medicine, organ transplantation has been providing benefits to patients suffering from an end stage chronic disease that lead to organ dysfunction and cannot be treated with normal medication.

Transplant diagnostics are the tests conducted before or after transplant in order to check the compatibility betwesen the donor and recipient of organ. It is an important component of clinical evaluations of multiple attributes related to donor organ screening and recipient surveillance.

The North America is currently holding the highest market share, owing to a significant rise in prevalence of chronic diseases, increase in adoption rate of transplant of organs, and surge in need for efficient & effective management of transplant diagnostic methods.

The Asia-Pacific region, at the same time, is expected to witness the fastest growth rate. This is due to certain factors such as rise in number of geriatric population who need kidney dialysis services, the huge base of hospital & transplant centers, and surge in R&D activities in the emerging economies like India, China, others. A significant increase in awareness regarding donation of organs among millennials is also contributing to the growth of the market to a great extent.

With this drift on board, several biotechnology enterprises have sparked interest in investing more in the development of innovative organ transplant diagnostic tools. They are focusing on the development of reliable transplant diagnostic solutions for research purposes that can help transplant physicians and researchers in better understanding the intricacies of transplant treatment. For instance, a company named Natera has recently launched its latest addition to transplant monitoring portfolio i.e. Prospera donor derived transplant assessment test for lung transplant recipients. This factor is augmenting the growth of the global transplant diagnostic market in more than one way.

In addition, numerous key market players are adopting strategies such as partnerships, collaborations, and acquisitions in order to stay competitive in the market. For example, Siemens in partnership with Thermo Fisher Scientific integrated Thermo Fisher Scientific’s real time PCR technology that can offer fast & sensitive detection limit, thereby can enhance the overall duration and quality of diagnostics. Also, Thermo Fisher Scientific acquired Linkage Biosciences with an aim to provide services to more than 1000 transplant centers in over 60 countries. Here it is worth mentioning that the global transplant diagnostic market has a great scope to gather immense growth opportunities in the near future

Related Post